findmyKOL
Clinical trialNCT01838499TerminatedPhase 2Interventional

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

SponsorAstraZenecaEnrollment224Hidradenitis Suppurativa
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Research Site

    Phoenix, Arizona, United States

  • Research Site

    Bakersfield, California, United States

  • Research Site

    Fremont, California, United States

  • Research Site

    Los Angeles, California, United States

  • Research Site

    San Diego, California, United States

  • Research Site

    San Francisco, California, United States

  • Research Site

    Miami, Florida, United States

  • Research Site

    Orange Park, Florida, United States

  • Research Site

    Ormond Beach, Florida, United States

  • Research Site

    Tampa, Florida, United States

  • Research Site

    Atlanta, Georgia, United States

  • Research Site

    Macon, Georgia, United States

  • Research Site

    Skokie, Illinois, United States

  • Research Site

    West Dundee, Illinois, United States

  • Research Site

    Evansville, Indiana, United States

  • Research Site

    Indianapolis, Indiana, United States

  • Research Site

    Rockville, Maryland, United States

  • Research Site

    St Louis, Missouri, United States

  • Research Site

    Forest Hills, New York, United States

  • Research Site

    Chapel Hill, North Carolina, United States

  • Research Site

    High Point, North Carolina, United States

  • Research Site

    Winston-Salem, North Carolina, United States

  • Research Site

    Hershey, Pennsylvania, United States

  • Research Site

    Philadelphia, Pennsylvania, United States

  • Research Site

    Rapid City, South Dakota, United States

  • Research Site

    Arlington, Texas, United States

  • Research Site

    Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2013
Primary completion
31 Oct 2014
Completion
31 Oct 2014
Last update posted
1 Sept 2016
Registered enrollment
224
Registry id
NCT01838499

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.